Crohn’s disease

Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup
Fierce Biotech
Thu, 05/11/23 - 11:02 am
Takeda
R&D
gene therapy
earnings
Crohn’s disease
Prometheus Biosciences Catapults 176% On Promising Results In UC and Crohn's
Investors Business Daily
Wed, 12/7/22 - 09:40 am
Prometheus Biosciences
clinical trials
ulcerative colitis
Crohn’s disease
Pushing for top spot in Big Pharma, AbbVie lands a key approval for its blockbuster Skyrizi
Endpoints
Mon, 06/20/22 - 10:33 am
AbbVie
Skyrizi
FDA
Crohn’s disease
Third positive trial sets up filings for AbbVie’s Rinvoq in Crohn’s
Pharmaforum
Thu, 05/12/22 - 10:46 am
AbbVie
Rinvoq
clinical trials
Crohn’s disease
What AbbVie's Recent Drug News Means for Shareholders
Motley Fool
Tue, 12/28/21 - 10:57 am
AbbVie
Skyrizi
Crohn’s disease
Europe
AbbVie's Rinvoq notches Crohn's disease win amid classwide JAK safety concerns
Fierce Pharma
Mon, 12/6/21 - 11:45 pm
AbbVie
Rinvoq
Crohn’s disease
AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohn’s disease
Pharmaceutical Business Review
Wed, 12/1/21 - 10:22 am
AbbVie
Europe
EMA
Skyrizi
Crohn’s disease
Theravance takes a gut punch as J&J-partnered JAK drug flops key test in ulcerative colitis
Endpoints
Mon, 08/23/21 - 11:26 pm
Theravance
izencitinib
ulcerative colitis
Crohn’s disease
clinical trials
AbbVie's Skyrizi takes home a win in late-stage Crohn's study, adding some heft to its expansion plans
Endpoints
Wed, 06/2/21 - 10:55 am
AbbVie
Skyrizi
clinical trials
Crohn’s disease
Eli Lilly's mirikizumab improves fatigue in patients with Crohn's disease in Phase 2 trial
Seeking Alpha
Wed, 05/26/21 - 11:34 pm
Eli Lilly
mirikizumab
clinical trials
Crohn’s disease
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
Fierce Biotech
Fri, 01/3/20 - 10:02 am
Janssen
Provention Bio
Crohn’s disease
PRV-6527
JNJ
Microbiome Report for the week ending 7-29-18
CP Wire
Wed, 08/1/18 - 11:49 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Microbiome Report for the week ending 7-29-18
Wed, 08/1/18 - 11:48 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Endpoints
Fri, 01/5/18 - 10:05 am
Takeda
TiGenix
M&A
Crohn’s disease
gene therapy
Cx601
How Big of a Deal Is Celgene's Flop?
Motley Fool
Sat, 10/21/17 - 10:23 am
Celgene
GED-301
Crohn’s disease
ozanimod
Otezla
Celgene just lost a crucial drug for its revenue stream after a clinical trial blowup
Stat
Thu, 10/19/17 - 06:31 pm
Celgene
Crohn’s disease
clinical trials
Mongersen
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Fri, 10/14/16 - 11:42 am
Crohn’s disease
HIV
vedolizumab
Entyvio
Takeda
AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
AbbVie
Boehringer Ingelheim
M&A
psoriasis
Crohn’s disease
asthma